Published in Biochem Mol Biol Int on December 01, 1997
Childhood asthma may be a consequence of vitamin D deficiency. Curr Opin Allergy Clin Immunol (2009) 1.62
Vitamin D deficiency and chronic lung disease. Can Respir J (2009) 1.11
Fat-soluble vitamins and atopic disease: what is the evidence? Proc Nutr Soc (2011) 0.81
Vitamin D deficiency is associated with increased human sinonasal fibroblast proliferation in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol (2016) 0.75
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J (1995) 3.48
Common and interchangeable elements in the promoters of genes transcribed by RNA polymerase iii. Cell (1983) 2.94
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood (2001) 2.92
Cloning of several cDNA segments coding for human liver proteins. EMBO J (1983) 2.32
Structure and expression of the human haptoglobin locus. EMBO J (1985) 2.09
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett (1991) 1.58
Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J (2005) 1.55
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J (1998) 1.50
Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med (2001) 1.43
Establishment and characterization of a human neuroblastoma cell line. Int J Cancer (1989) 1.43
Cloning and sequencing of a full length cDNA coding for a human apoferritin H chain: evidence for a multigene family. EMBO J (1984) 1.42
[Malaria in Italy in 1902. Epidemiological and preventive research]. Parassitologia (2003) 1.40
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res (1992) 1.39
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? J Thromb Haemost (2005) 1.38
[Marshy and Anopheles-infested (malarial) conditions without malaria. 1902 ]. Parassitologia (2002) 1.38
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest (1999) 1.37
Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucleic Acids Res (1983) 1.36
Group B streptococci persist inside macrophages. Immunology (1998) 1.36
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem (2001) 1.32
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst (1997) 1.30
Sequence of human haptoglobin cDNA: evidence that the alpha and beta subunits are coded by the same mRNA. Nucleic Acids Res (1983) 1.29
Slow folding of muscle acylphosphatase in the absence of intermediates. J Mol Biol (1998) 1.26
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ (2008) 1.18
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol (1992) 1.15
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer (1993) 1.15
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. Science (1987) 1.10
Expression, purification, and characterization of acylphosphatase muscular isoenzyme as fusion protein with glutathione S-transferase. Protein Expr Purif (1995) 1.09
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res (1999) 1.08
IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci (1995) 1.08
Biocompatibility evaluation of surface-treated AISI 316L austenitic stainless steel in human cell cultures. J Biomed Mater Res A (2007) 1.08
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol (1987) 1.07
Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology (1997) 1.06
Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ (1991) 1.05
The role of Cys12, Cys17 and Arg18 in the catalytic mechanism of low-M(r) cytosolic phosphotyrosine protein phosphatase. Eur J Biochem (1993) 1.04
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.04
Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol (1990) 1.02
A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett (2008) 1.02
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. Biochem Biophys Res Commun (1999) 1.01
Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. Eur J Cell Biol (1984) 1.01
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol (1999) 1.01
PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1995) 1.00
Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem (2000) 0.99
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest (1996) 0.99
Human interleukin-1 beta gene. Gene (1987) 0.98
Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today (1997) 0.98
Aspartic-129 is an essential residue in the catalytic mechanism of the low M(r) phosphotyrosine protein phosphatase. FEBS Lett (1994) 0.97
Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood (1997) 0.97
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol (1994) 0.95
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol (1995) 0.95
c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells. Biochem Biophys Res Commun (1997) 0.95
Horse muscle acyl phosphatase: purification and some properties. Arch Biochem Biophys (1969) 0.94
Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry (1996) 0.94
Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Hepatology (1999) 0.94
An inducible enhancer controls the expression of the human interleukin 1 beta gene. Cell Growth Differ (1990) 0.92
The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase. FEBS Lett (1999) 0.92
Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res (1993) 0.91
Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma. Exp Cell Res (1996) 0.90
The molecular basis of the differing kinetic behavior of the two low molecular mass phosphotyrosine protein phosphatase isoforms. J Biol Chem (1996) 0.90
The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling. J Biol Chem (1998) 0.90
LMW-PTP is a negative regulator of insulin-mediated mitotic and metabolic signalling. Biochem Biophys Res Commun (1997) 0.89
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation. J Thromb Haemost (2005) 0.89
Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol (1995) 0.89
Molecular evidence of triplication in the haptoglobin Johnson variant gene. Hum Genet (1985) 0.89
Neutrophils in anti-cancer immunological strategies: old players in new games. J Hematother Stem Cell Res (2001) 0.89
Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts. Cell Mol Life Sci (2006) 0.89
Arginine-23 is involved in the catalytic site of muscle acylphosphatase. Biochim Biophys Acta (1994) 0.89
Expression of the small tyrosine phosphatase (Stp1) in Saccharomyces cerevisiae: a study on protein tyrosine phosphorylation. Electrophoresis (2001) 0.89
Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? Prog Clin Biol Res (1990) 0.88
An ultrastructural study of recurrent disc herniation: a preliminary report. Spine (Phila Pa 1976) (1983) 0.88
Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents (2013) 0.88
Different carbon sources affect lifespan and protein redox state during Saccharomyces cerevisiae chronological ageing. Cell Mol Life Sci (2009) 0.88
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V. Br J Haematol (1997) 0.87
Insulin inhibits platelet-derived growth factor-induced cell proliferation. Mol Biol Cell (2004) 0.87
Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. J Biol Chem (2001) 0.86
Differential expression of the human IL-1 alpha and beta genes. Prog Clin Biol Res (1990) 0.86
Use of amino acid-analyzer for identification of 3H labelled C-terminal amino acid. Experientia (1971) 0.86
Acylphosphatase expression during macrophage differentiation and activation of U-937 cell line. Biochimie (1999) 0.85
Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc Natl Acad Sci U S A (1992) 0.85
Remarks on the Epidemiology and Prophylaxis of Malaria in the Light of Recent Researches. Br Med J (1900) 0.85
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood (1997) 0.85
Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells. Neurochem Res (1999) 0.85
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. Blood (2000) 0.85
Heavy metal toxicity following apical and basolateral exposure in the human intestinal cell line Caco-2. Toxicol In Vitro (1996) 0.85
Biocompatibility studies of low temperature nitrided and collagen-I coated AISI 316L austenitic stainless steel. J Mater Sci Mater Med (2013) 0.84
A new acylphosphatase isoenzyme from human erythrocytes: purification, characterization, and primary structure. Biochemistry (1986) 0.84
[Bone marrow changes in HIV-positive patients (clinical, cytological, histological, and ultrastructural study of 57 cases)]. Pathologica (1997) 0.84
Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations. Hum Mutat (1995) 0.84
HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol (1999) 0.84
LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. Biochem Biophys Res Commun (2000) 0.84
Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. J Biol Regul Homeost Agents (2012) 0.83